[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345322-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345322-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-a-germline-xaf1-mutation-in-patients-with-gastrointestinal-cancers-research-article","Identification of a Germline XAF1 Mutation in Patients With Gastrointestinal Cancers - Research Article","","Gastrointestinal cancers involve genetic and environmental influences, yet the hereditary genetic drivers of familial cases remain insufficiently defined. Blood from six affected family members was analyzed by whole-exome sequencing to detect germline candidates, followed by frequency assessment in 148 gastrointestinal cancer patients and 283 cancer-free controls using Sanger sequencing. For functional relevance, immunofluorescence was used to measure XAF1 protein expression in resected tumor tissues from carriers and non-carriers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-a-germline-xaf1-mutation-in-patients-with-gastrointestinal-cancers-research-article/345322/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-a-germline-xaf1-mutation-in-patients-with-gastrointestinal-cancers-research-article/345322.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What genetic variant did the study identify in the family?","Question",{"text":63,"@type":64},"The study identified a germline XAF1 mutation (c.454+1372G>A), described as a nonsense mutation in Exon 4b that produces a truncated XAF1 isoform.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the mutation frequency evaluated across patient and control groups?",{"text":68,"@type":64},"Candidate mutations were tested by Sanger sequencing, and the frequency of the suspected mutation was determined in 148 gastrointestinal cancer patients and 283 cancer-free controls to assess enrichment in cases.",{"name":70,"@type":61,"acceptedAnswer":71},"What did immunofluorescence show about XAF1 expression?",{"text":72,"@type":64},"Immunofluorescence assays showed lower XAF1 protein expression in tumors from the mutated group compared with the nonmutated group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345322,1790181867,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Human Mutation  \nRESEARCH ARTICLE  OPEN ACCESS   \nIdentification of a Germline XAF1 Mutation in Patients With Gastrointestinal Cancers  \nGuan-Xin Xu1 | Hang Zhang2 | Chang-Xing Wang3 | Ying-Zhi Zhang4 | Ping-Ping Lv5,6 | Chun Feng6 ,7 | Yao Ning8 | Miao Shen8 | Sai Zhang1 | Min Jin6 ,7 | Dan-Qing Yu6 ,7  \n1Department of Thoracic Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China | 2Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China | 3Department of Pathology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China | 4Department of Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China | 5Department of Reproductive Medicine, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China | 6Key Laboratory of Reproductive Genetics, Ministry of Education (Zhejiang University), Hangzhou, Zhejiang Province, China | 7Department of Reproductive Medicine, The Second Affiliated Hospital of Zhejiang University, Hangzhou,  \nChina | 8Department of Gynaecology and Obstetrics, The First People’s Hospital of Jiande, Hangzhou, Zhejiang Province, China Correspondence: Min Jin ([min_jin@zju.edu.cn](min_jin@zju.edu.cn)) | Dan-Qing Yu ([ydq1002@zju.edu.cn](ydq1002@zju.edu.cn))  \nReceived: 21 December 2024 | Revised: 9 December 2025 | Accepted: 3 April 2026  \nAcademic Editor: Hannah Wesley  \nABSTRACT  \nBackground: Gastrointestinal (GI) cancers can be attributed to the interplay between genetic and environmental factors. To date, apart from certain cancer syndromes, the genetic factors underlying familial GI cancers have not been clearly elucidated. Methods: Blood samples were collected from six members of a family with GI cancer for whole exome sequencing to identify suspicious germline mutations. Subsequently, 148 patients with GI cancers (including esophageal and gastric cancers) and 283 cancer-free patients were recruited. The frequency of the suspected mutations in both groups was determined using Sanger sequencing. Furthermore, immunofluorescence (IF) assays for XAF1 protein expression were performed in paraffin-embedded surgically resected tumor tissues from patients with GI cancer, with or without the mutation.  \nResults: In a family with GI cancer, we identified a mutation of XAF1 (c.454+1372G>A), which is a nonsense mutation in Exon 4b that results in a truncated XAF1 Isoform 5. Sanger sequencing of sporadic cancer patients and cancer-free populations further verified that the frequency of this mutation was enriched in patients with GI cancer. Additionally, IF assays revealed that XAF1 protein expression was lower in the mutated group than in the nonmutated group.  \nConclusion: Our study provides evidence that aXAF1 mutation (c.454+1372G>A) leads to repressed expression of XAF1 and is associated with a predisposition to GI tumorigenesis, especially in esophageal and gastric cancers.  \n1 | Introduction  \nGastrointestinal (GI) cancers encompass a spectrum of malignancies affecting the digestive system ([1]) . While most GI cancers are sporadic, approximately 3%–10% of gastric, liver, or other GI cancers exhibit familial clustering [2 , 3] . The genetic alterations involved in GI cancers are mainly observed in oncogenes, tumor suppressor genes, and DNA repair genes. Some common genes are involved in various GI cancers [1],  \nincluding the MDM2 T309G polymorphism, which has been linked to susceptibility to colon [4], gastric [5], and hepatocellular cancers [6] . Biallelic mutations (Muts) in MUTYH are associated with MUTYH-associated polyposis, which increases the risk of colorectal and duodenal cancer [7, 8] . Other genes, including OGG1, XRCC1, PARP1, TGFβ, TGFBR1, and SMAD7, exhibit associations with multiple GI cancers [9–14] . Germline Muts in TP53 are the causal genetic defects in Li–Fraumeni s","cbCaitwdRrKCwjS0","https://ap.wps.com/l/cbCaitwdRrKCwjS0","pdf",4036161,12,"English","# Introduction\n## Genetic factors in gastrointestinal cancers\n## XAF1 and its reported roles\n# Results\n## Family pedigree with high gastrointestinal cancer incidence","[{\"question\":\"What genetic variant did the study identify in the family?\",\"answer\":\"The study identified a germline XAF1 mutation (c.454+1372G\\u003eA), described as a nonsense mutation in Exon 4b that produces a truncated XAF1 isoform.\"},{\"question\":\"How was the mutation frequency evaluated across patient and control groups?\",\"answer\":\"Candidate mutations were tested by Sanger sequencing, and the frequency of the suspected mutation was determined in 148 gastrointestinal cancer patients and 283 cancer-free controls to assess enrichment in cases.\"},{\"question\":\"What did immunofluorescence show about XAF1 expression?\",\"answer\":\"Immunofluorescence assays showed lower XAF1 protein expression in tumors from the mutated group compared with the nonmutated group.\"}]","Identification of a Germline XAF1 Mutation in Patients With Gastrointestinal Cancers - Research Article | PDF",1790057288,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7226787fd4abe5bf441d2e23fc7b9fc.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45db4377a0b80305ee303f9f2d11a9b3.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dff01741a82de3b3f3f3f9d3904ff1e.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fc5bb30d61fe4acce2944cc25e3ab47.webp",980,1287]